By identifying phenotypes that are shared among tumors with different aneuploidies, we hope to discover pathways that can be manipulated to selectively
eliminate aneuploid cells or to block aneuploidy's non-cell autonomous effects.
We're working to understand how aneuploidy impacts cancer progression, in hopes of developing therapies that can specifically
eliminate aneuploid cancers while leaving normal cells unharmed.